|
NDFIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.347600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.955000E-01 |
| Normal-vs-Stage2 |
3.940600E-01 |
| Normal-vs-Stage3 |
2.565800E-01 |
| Normal-vs-Stage4 |
1.680970E-01 |
| Stage1-vs-Stage2 |
3.571000E-01 |
| Stage1-vs-Stage3 |
2.296000E-01 |
| Stage1-vs-Stage4 |
1.810050E-01 |
| Stage2-vs-Stage3 |
7.565800E-01 |
| Stage2-vs-Stage4 |
5.652400E-01 |
| Stage3-vs-Stage4 |
8.306000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.824000E-01 |
| Normal-vs-AfricanAmerican |
5.778800E-01 |
| Normal-vs-Asian |
1.214980E-01 |
| Caucasian-vs-AfricanAmerican |
9.894400E-01 |
| Caucasian-vs-Asian |
2.777000E-01 |
| AfricanAmerican-vs-Asian |
2.401000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.500800E-01 |
| Normal-vs-Female |
8.741400E-01 |
| Male-vs-Female |
5.356200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.908200E-01 |
| Normal-vs-Extreme_Weight |
4.522400E-01 |
| Normal-vs-Obese |
2.019200E-01 |
| Normal-vs-Extreme_Obese |
8.019800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.307200E-01 |
| Normal_Weight-vs-Obese |
2.000400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.804400E-01 |
| Extreme_Weight-vs-Obese |
5.947700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.287000E-01 |
| Obese-vs-Extreme_Obese |
7.461400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.956990E-01 |
| Normal-vs-Age(41-60Yrs) |
8.022500E-02 |
| Normal-vs-Age(61-80Yrs) |
8.710200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.763400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.945600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.382400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.628200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.384000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.575000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.737800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.584800E-01 |
| Normal-VS-Type2 PRCC |
2.593000E-01 |
| Normal-VS-KIRP CIMP |
4.966100E-02 |
| Normal-VS-Unclassified PRCC |
1.507990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.759400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.264200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.887810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.916900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.427600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.496500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.175600E-01 |
| Normal-vs-N1 |
1.305430E-01 |
| Normal-vs-N2 |
1.59780999999803E-05 |
| N0-vs-N1 |
1.051390E-01 |
| N0-vs-N2 |
3.396800E-03 |
| N1-vs-N2 |
3.355500E-03 |
|
|
